Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
The Cochrane Database of Systematic Reviews|October 7, 2020
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesisCatherine Houghton, Maura Dowling, Pauline Meskell, et al.Journal of Thoracic Disease|November 17, 2022
The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancerCamille V Edwards, Ayesha R Sheikh, Michael J Dennis, et al.Clinical Trials (London, England)|April 5, 2024
The overlap between randomised evaluations of recruitment and retention interventions: An updated review of recruitment (Online Resource for Recruitment in Clinical triAls) and retention (Online Resource for Retention in Clinical triAls) literatureAnna Kearney, Laura Butlin, Taylor Coffey, et al.The Cochrane Database of Systematic Reviews|March 6, 2021
Strategies to improve retention in randomised trialsKatie Gillies, Anna Kearney, Ciara Keenan, et al.Irish Journal of Medical Science|January 15, 2021
Virtual oncology clinics during the COVID-19 pandemicDavid O'Reilly, Hailey Carroll, Mairi Lucas, et al.The Lancet. Oncology|January 9, 2013
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trialPirkko-Liisa Kellokumpu-Lehtinen, Ulrika Harmenberg, Timo Joensuu, et al.Nano Letters|July 17, 2023
Electronic Structure of Few-Layer Black Phosphorus from μ-ARPESFlorian Margot, Simone Lisi, Irène Cucchi, et al.Clinical and Translational Radiation Oncology|January 23, 2023
Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysisJacqueline Steinke, Chloe Jordan, Savvas Rossides, et al.Trials|October 6, 2017
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trialGráinne Sheill, Lauren Brady, Emer Guinan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced MelanomaMario Sznol, Pier Francesco Ferrucci, David Hogg, et al.Pageof 16